A US pharmaceutical services client engaged CIL to help identify opportunities for European expansion.
CIL’s advanced analytics team first extracted complex and challenging data sets involving clinical trial information from the World Health Organisation and other large-scale European health and governmental institutions. The team cleaned, processed and merged these datasets to identify the total number of active clinical trials by site and sponsor type in each European country.
When the wide-scale opportunity was understood, CIL undertook a detailed site-level analysis that provided an in-country view of the level of purchasing consolidation and the distribution of sites by size and type in a specific country. This granular analysis helped to prioritize countries for European expansion.
The analysis proved instrumental in quantifying the scale of the European opportunity and informing the business’s international expansion strategy. The work clearly identified countries that were most attractive to prioritize, and the site-level analysis provided a useful starting list of sales contacts (pre-quantified by scale and type of customer).
The business found the research so useful in identifying growth opportunities, CIL was re-engaged to perform the same analysis on its home market.
Liam is the partner in charge of our advanced analytics practice, and also leads our consumer sector work.
James is CIL’s advanced analytics manager, with oversight over all of CIL’s advanced analytics engagements